Newsfeeds - Spark Newswire

1 minute read

News

Predictive Oncology Partners With Cancer Research Horizons To Leverage AI For New Cancer Drugs

March 21, 1:59 PM

Predictive Oncology chief business officer Pamela Bush and Dom Pollard, business development manager at Cancer Research Horizons, join Proactive's Natalie Stoberman to discuss their new partnership for new cancer

POAI

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

March 3, 5:31 PM

Gainers MyMD Pharmaceuticals (NASDAQ:MYMD) stock rose 11.9% to $2.25 during Friday’s after-market session. The market value of their…

CDIO

4 minute read

Why Hempacco Are Trading Lower By 58%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

February 10, 2:07 PM

Gainers SeqLL Inc. (NASDAQ: SQL) shares jumped 120% to $1.85 after dropping around 39% on Thursday. SeqLL recently announced the establishment of a two-year Cooperative Research and Development Agreement with the U.S. Department of Justice's Federal Bureau of Investigation.

$APE

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

February 6, 9:06 AM

Gainers Catalent (NYSE:CTLT) shares increased by 27.6% to $71.5 during Monday’s pre-market session. The market value of their…

ADIL

4 minute read

Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

December 7, 2:45 PM

Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint.

ALVO

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

December 5, 5:32 PM

Gainers Ambrx Biopharma (NYSE:AMAM) shares increased by 9.3% to $0.57 during Monday’s after-market session. This security traded at…

AMAM

1 minute read

Predictive Oncology Q3 EPS $(0.05) Up From $(0.08) YoY, Sales $455.83M Up From $313.66K YoY

By Benzinga Newsdesk

November 10, 6:17 PM

Predictive Oncology (NASDAQ:POAI) reported quarterly losses of $(0.05) per share. This is a 37.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported $455.83 million in

POAI